Neoadjuvant Chemotherapy for High-risk Intrahepatic Cholangiocarcinoma – Does Pathologic Response Mean Better Outcomes?. (2022) - Arango, N. Paez; Ayabe, R.; Jeannelyn, E.; Newhook, T.; Tzeng, C.-W.D.; Chun, Y.S.; Lee, S.; Javle, M.; Vauthey, J.-N.; Cao, H.S. Tran